EVERTEC (EVTC) Competitors

HealthEquity (NASDAQ:HQY) and EVERTEC (NYSE:EVTC) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, community ranking, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.

Does the media prefer HQY or EVTC?

In the previous week, EVERTEC had 4 more articles in the media than HealthEquity. MarketBeat recorded 10 mentions for EVERTEC and 6 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.07 beat EVERTEC's score of 0.89 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
EVERTEC	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer HQY or EVTC?

HealthEquity received 249 more outperform votes than EVERTEC when rated by MarketBeat users. Likewise, 70.04% of users gave HealthEquity an outperform vote while only 59.29% of users gave EVERTEC an outperform vote.

Company	Underperform	Outperform
HealthEquity	Outperform Votes 533 70.04%	Underperform Votes 228 29.96%
EVERTEC	Outperform Votes 284 59.29%	Underperform Votes 195 40.71%

Do insiders & institutionals have more ownership in HQY or EVTC?

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 96.8% of EVERTEC shares are held by institutional investors. 2.2% of HealthEquity shares are held by insiders. Comparatively, 0.8% of EVERTEC shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has more risk and volatility, HQY or EVTC?

HealthEquity has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500. Comparatively, EVERTEC has a beta of 1.16, suggesting that its share price is 16% more volatile than the S&P 500.

Do analysts recommend HQY or EVTC?

HealthEquity currently has a consensus target price of $110.71, indicating a potential upside of 16.60%. EVERTEC has a consensus target price of $35.00, indicating a potential upside of 4.14%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts plainly believe HealthEquity is more favorable than EVERTEC.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	0 Sell rating(s)	1 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.93
EVERTEC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Which has stronger valuation and earnings, HQY or EVTC?

EVERTEC has lower revenue, but higher earnings than HealthEquity. EVERTEC is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.15B	7.15	$55.71M	$1.09	87.11
EVERTEC	$823.71M	2.60	$79.72M	$1.28	26.26

Is HQY or EVTC more profitable?

EVERTEC has a net margin of 10.20% compared to HealthEquity's net margin of 8.41%. EVERTEC's return on equity of 33.01% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	8.41%	9.70%	6.08%
EVERTEC	10.20%	33.01%	8.85%

Summary

HealthEquity beats EVERTEC on 11 of the 18 factors compared between the two stocks.